• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort.小儿T细胞淋巴母细胞淋巴瘤队列中遗传性错配修复缺陷的高患病率
Hemasphere. 2021 Dec 21;6(1):e668. doi: 10.1097/HS9.0000000000000668. eCollection 2022 Jan.
2
Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.先天性错配修复缺陷综合征背景下的急性淋巴细胞白血病和淋巴瘤
Eur J Med Genet. 2016 Mar;59(3):133-42. doi: 10.1016/j.ejmg.2015.12.014. Epub 2015 Dec 30.
3
Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.儿童难治性胶质母细胞瘤伴胚系双等位基因错配修复缺陷患者对纳武利尤单抗的持久应答。
Oncologist. 2018 Dec;23(12):1401-1406. doi: 10.1634/theoncologist.2018-0163. Epub 2018 Aug 13.
4
Comprehensive analysis of constitutional mismatch repair deficiency-associated non-Hodgkin lymphomas in a global cohort.全球队列中错配修复缺陷相关性非霍奇金淋巴瘤的综合分析。
Pediatr Blood Cancer. 2024 Dec;71(12):e31302. doi: 10.1002/pbc.31302. Epub 2024 Sep 19.
5
Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.遗传和临床决定因素导致的错配修复缺陷综合征:来自错配修复缺陷综合征联盟的报告。
Eur J Cancer. 2014 Mar;50(5):987-96. doi: 10.1016/j.ejca.2013.12.005. Epub 2014 Jan 15.
6
Demystifying the Mystery of Genes: A Case Report on Constitutional Mismatch Repair Deficiency.揭开基因之谜:一例先天性错配修复缺陷病例报告
Indian J Radiol Imaging. 2024 Apr 21;34(3):562-565. doi: 10.1055/s-0044-1779586. eCollection 2024 Jul.
7
Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).先天性错配修复缺陷综合征的诊断标准:欧洲“关爱CMMRD”(C4CMMRD)联盟的建议
J Med Genet. 2014 Jun;51(6):355-65. doi: 10.1136/jmedgenet-2014-102284. Epub 2014 Apr 15.
8
Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.免疫疗法是先天性错配修复缺陷(CMMRD)综合征癌症治疗和预防的关键。
Cancer Lett. 2017 Sep 10;403:159-164. doi: 10.1016/j.canlet.2017.06.018. Epub 2017 Jun 20.
9
Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.从非肿瘤组织中进行功能性修复检测以诊断先天性错配修复缺陷。
J Clin Oncol. 2019 Feb 20;37(6):461-470. doi: 10.1200/JCO.18.00474. Epub 2019 Jan 4.
10
Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.先天性错配修复缺陷综合征与1型神经纤维瘤病之间的关联。
Clin Genet. 2017 Apr;91(4):507-519. doi: 10.1111/cge.12904. Epub 2017 Jan 10.

引用本文的文献

1
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiency.揭示影响遗传性错配修复缺陷个体肿瘤突变模式的诱变过程。
Nat Commun. 2025 May 14;16(1):4459. doi: 10.1038/s41467-025-59775-2.
2
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia.儿童急性淋巴细胞白血病的显性和隐性遗传病因
Leukemia. 2025 May;39(5):1031-1045. doi: 10.1038/s41375-025-02535-4. Epub 2025 Mar 24.
3
ERN GENTURIS guidelines on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management.ERN GENTURIS 指南:关于错配修复缺陷诊断、遗传咨询、监测、生活质量和临床管理的建议。
Eur J Hum Genet. 2024 Dec;32(12):1526-1541. doi: 10.1038/s41431-024-01708-6. Epub 2024 Oct 17.
4
Clinical Insights and Potential Benefits of Stem Cell Transplantation for Constitutional Mismatch Repair Deficiency: A Case Report of Two Siblings.干细胞移植治疗先天性错配修复缺陷的临床见解及潜在益处:两例同胞病例报告
Cureus. 2024 Aug 8;16(8):e66441. doi: 10.7759/cureus.66441. eCollection 2024 Aug.
5
T-cell lymphoblastic lymphoma in constitutional mismatch repair deficiency (CMMRD): Exploring treatment opportunities.先天性错配修复缺陷(CMMRD)中的T细胞淋巴母细胞淋巴瘤:探索治疗机会。
Hemasphere. 2024 May 12;8(5):e73. doi: 10.1002/hem3.73. eCollection 2024 May.
6
Resolving inherited and germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies.通过全外显子组三联体分析解析儿童血液系统恶性肿瘤中的遗传性和种系易感性序列变异
Front Pediatr. 2023 Feb 7;10:1080347. doi: 10.3389/fped.2022.1080347. eCollection 2022.

本文引用的文献

1
Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance.儿科 T 细胞淋巴母细胞淋巴瘤的综合基因组分析揭示了具有临床意义的候选基因。
Blood. 2021 Apr 29;137(17):2347-2359. doi: 10.1182/blood.2020005381.
2
T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?T 细胞淋巴母细胞淋巴瘤和白血病:来自共同前恶性前体细胞的不同疾病?
Blood Adv. 2020 Jul 28;4(14):3466-3473. doi: 10.1182/bloodadvances.2020001822.
3
Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.非霍奇金淋巴瘤治疗后的第二恶性肿瘤:189 例儿童和青少年的回顾性跨国研究。
Leukemia. 2021 Feb;35(2):534-549. doi: 10.1038/s41375-020-0841-x. Epub 2020 May 11.
4
MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.在小儿 B 淋巴细胞白血病缓解期 MSH6 杂合性缺失导致巯嘌呤耐药的发生。
Haematologica. 2018 May;103(5):830-839. doi: 10.3324/haematol.2017.176362. Epub 2018 Feb 15.
5
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.欧洲协作组 EURO-LB02 临床试验在儿童和青少年淋巴母细胞淋巴瘤中的结果和结论。
Haematologica. 2017 Dec;102(12):2086-2096. doi: 10.3324/haematol.2015.139162. Epub 2017 Oct 5.
6
Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool.识别儿科癌症患者的遗传易感性:一种易于使用的选择工具。
Eur J Med Genet. 2016 Mar;59(3):116-25. doi: 10.1016/j.ejmg.2016.01.008. Epub 2016 Jan 26.
7
Revised International Pediatric Non-Hodgkin Lymphoma Staging System.修订后的国际儿童非霍奇金淋巴瘤分期系统
J Clin Oncol. 2015 Jun 20;33(18):2112-8. doi: 10.1200/JCO.2014.59.7203. Epub 2015 May 4.
8
Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).先天性错配修复缺陷综合征的诊断标准:欧洲“关爱CMMRD”(C4CMMRD)联盟的建议
J Med Genet. 2014 Jun;51(6):355-65. doi: 10.1136/jmedgenet-2014-102284. Epub 2014 Apr 15.
9
A Dutch Fanconi Anemia FANCC Founder Mutation in Canadian Manitoba Mennonites.加拿大曼尼托巴省门诺派人群中发现的荷兰范可尼贫血症FANCC奠基者突变。
Anemia. 2012;2012:865170. doi: 10.1155/2012/865170. Epub 2012 Jun 4.
10
Recurrent and founder mutations in the PMS2 gene.PMS2 基因中的反复出现和创始性突变。
Clin Genet. 2013 Mar;83(3):238-43. doi: 10.1111/j.1399-0004.2012.01898.x. Epub 2012 Jun 4.

小儿T细胞淋巴母细胞淋巴瘤队列中遗传性错配修复缺陷的高患病率

High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort.

作者信息

Kroeze Emma, Weijers Dilys D, Hagleitner Melanie M, de Groot-Kruseman Hester A, Jongmans Marjolijn C J, Kuiper Roland P, Pieters Rob, Meijerink Jules P P, Loeffen Jan L C

机构信息

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Department of Genetics, University Medical Center Utrecht, The Netherlands.

出版信息

Hemasphere. 2021 Dec 21;6(1):e668. doi: 10.1097/HS9.0000000000000668. eCollection 2022 Jan.

DOI:10.1097/HS9.0000000000000668
PMID:34964038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8697338/
Abstract

This study describes the clinical characteristics of a complete Dutch T-cell lymphoblastic lymphoma (T-LBL) cohort, including second primary malignancies and comorbidities. We show that over 10% of patients in this complete T-LBL cohort have been diagnosed with a cancer predisposition syndrome (CPS), consisting almost exclusively of constitutional mismatch repair deficiency (CMMRD). The clinical characteristics of sporadic T-LBL patients were compared with T-LBL patients that have been diagnosed with CMMRD. This shows that disease presentation is comparable but that disease localization in CMMRD patients might be more localized. The percentage of CPS seems reliable considering the completeness of the cohort of Dutch T-LBL patients and might even be an underestimation (possibility of undiagnosed CPS patients in cohort). As the frequency of an underlying predisposition syndrome among T-LBL patients may be underestimated at present, we advocate for screening all pediatric T-LBL patients for the presence of germline mutations in mismatch repair genes.

摘要

本研究描述了一个完整的荷兰T细胞淋巴母细胞淋巴瘤(T-LBL)队列的临床特征,包括第二原发性恶性肿瘤和合并症。我们发现,在这个完整的T-LBL队列中,超过10%的患者被诊断患有癌症易感综合征(CPS),几乎全部由遗传性错配修复缺陷(CMMRD)组成。将散发性T-LBL患者的临床特征与已诊断为CMMRD的T-LBL患者进行了比较。这表明疾病表现具有可比性,但CMMRD患者的疾病定位可能更局限。考虑到荷兰T-LBL患者队列的完整性,CPS的百分比似乎是可靠的,甚至可能被低估了(队列中可能存在未被诊断的CPS患者)。由于目前T-LBL患者中潜在易感综合征的发生率可能被低估,我们主张对所有儿童T-LBL患者进行错配修复基因种系突变筛查。